Also categorized in PubMed:
Effectiveness of nationwide screening program for neuroblastoma in Japan.
x hide permanently

Reversible LSD1 inhibition with HCI-2509 induces the p53 gene expression signature and disrupts the MYCN signature in high-risk neuroblastoma cells.

ncbi.nlm.nih.gov

Reversible LSD1 inhibition with HCI-2509 induces the p53 gene expression signature and disrupts the MYCN signature in high-risk neuroblastoma cells.

Oncotarget. 2018 Feb 09;9(11):9907-9924

Authors: Gupta S, Doyle K, Mosbruger TL, Butterfield A, Weston A, Ast A, Kaadige M, Verma A, Sharma S

Mentions: MYCN